About MosaeQ

MosaeQ (Mosae Zorg Industries) is pioneering the future of quantum computing for biodefense and materials research through our revolutionary cislunar infrastructure. Founded by F. Hanna Campbell, M.E., B.E., we deliver unprecedented predictive power for pathogen forecasting and protein computation.

Our Mission

Accelerating pharmaceutical development through quantum-enhanced preclinical analysis while maintaining complete algorithm transparency and user data ownership.

We provide unprecedented computational power for solving humanity's most pressing biological and materials challenges through quantum computing positioned at the Earth-Moon L1 Lagrange point. We unlock the 95% of missing pathogen data that classical AI cannot predict, enabling proactive threat detection and breakthrough drug development.

Key Achievements

MethaneSAT Data Partnership

Exclusive access to real-time global methane concentration data for environmental stress correlation in drug stability predictions

ICH M3(R2) Regulatory Compliance

Full compliance with international harmonized guidelines for nonclinical safety studies (FDA, EMA, MHRA, PMDA)

Open Source Algorithm Transparency

Industry-first full algorithm transparency via GitHub - our advantage is quantum speed, not algorithm secrecy

GitHub User Data Ownership Model

Complete user control over analysis data - export directly to your repositories with zero vendor lock-in

The Technology

Our quantum computing infrastructure operates at the L1 Lagrange point, providing unique advantages for both computational stability and Earth observation:

  • Radio-Optic Detection: G-4 microbiosensor capture with high-precision radio-optics detecting G-4 innate quantum fluorescence
  • Quantum Computation: Patented quaternion processing executing 24,000x faster algorithms for scalable protein computation
  • Dynamic Genome Forecast: Generates 3D pathogen structures, evolution trajectories, and the missing 95% of sequence data
  • Cislunar Operation: Ultra-stable L1 environment minimizes decoherence and reduces operational costs

Market Opportunity

MosaeQ targets a multi-billion-dollar opportunity across three key markets:

  • Quantum-as-a-Service (QCaaS): 35% market share potential in the rapidly growing quantum computing sector
  • Biogenomic AI (Pathogen Forecast): 25% of the pathogen prediction and biosecurity market
  • Agri-Biotech AI (Food Safety): 10% of the food safety and agricultural biotechnology market

Our target customers include pharmaceutical AI companies, food manufacturers, and organizations requiring industrial certifications and HERA support for biosecurity applications.

Strategic Partnerships

MosaeQ is engaged with leading organizations in quantum computing, environmental monitoring, and space technology:

  • MethaneSAT: Real-time global methane concentration data integration for environmental stress correlation
  • Berlin Quantum / CERIC: Collaborative development of quantum algorithms and validation
  • Lunar Helium-3 Mining, LLC: Cislunar infrastructure and resource partnerships
  • Astrolab: Space operations and deployment support

Roadmap

2025
Secure IP - Finalizing patents for quantum algorithms and detection systems
2026
Configuration - Platform development and ground-based testing
2027
Constellation - Initial cislunar deployment and operational validation
2028
Globalization - Full commercial service launch and market expansion

Business Model

B2C: MosaeQ Global Pathogen Threat Map

Free access to public health data with early sign-ups for premium features

Additional Revenue: Biopharmaceutical IP for personalized 3D-print immunization streams (EMA-FDA combinatoric excipient pathway)

B2B: MosaeQ QaaS - Enterprise License

Dedicated License: €799.99/month

Enterprise License + cisLunar Real Estate: €3,799.99/month

Target customers: Pharma AI, Food AI manufacturers requiring industrial certifications and HERA support

Traction & Validation

Early Momentum & Validation

MosaeQ has demonstrated strong early traction with projected Year 1 to Year 2 revenue growth exceeding 1,350%

€1.13M

Year 1 Revenue (Projected)

€16.52M

Year 2 Revenue (Projected)

€66.38M

Year 3 Revenue (Projected)

Investment Direction

Total Startup Costs

€835,000

Top Startup Cost

€250,000

Advanced Quantum Computing Hardware

Year 1 Total Revenue (Projected)

€1.13M

(specifically, €1,133,208.86)

Total Financing Income

€11.15M

Leadership

F. Hanna Campbell, M.E., B.E.

CEO, Founder & Inventor

F. Hanna Campbell is the visionary founder of Mosae Zorg Industries (MosaeQ), pioneering quantum-enhanced predictive computing for biodefense and materials science.

Email: fhcampbell@mosaezorg.com

Phone: +49(0)3040817284 (International)

Website: mosaeq.com / mosaezorg.com

Cookie-Einstellungen

Wir verwenden Cookies und ähnliche Technologien, um die Funktionalität unserer Website zu gewährleisten und Ihr Nutzererlebnis zu verbessern. Einige Cookies sind technisch notwendig, während andere uns helfen, unsere Dienste zu optimieren.

Gemäß der DSGVO benötigen wir Ihre ausdrückliche Zustimmung für die Verwendung von nicht-notwendigen Cookies. Sie können Ihre Einstellungen jederzeit ändern.

Ihre Datenschutzrechte

Sie haben das Recht auf Auskunft, Berichtigung, Löschung und Einschränkung der Verarbeitung Ihrer personenbezogenen Daten. Weitere Informationen finden Sie in unserer Datenschutzerklärung und im Impressum.